entertainment -WSS

entertainment

author：knowledge 2025-08-25 07:27:12 - browse：86611

The artificial womb, a device aiming to save infants born way too soon, is inching closer to being tested in humans.

The technology is close enough to reality that the Food and Drug Administration has decided to convene a two-day panel starting Tuesday to discuss how to best evaluate safety and effectiveness, as well as the ethical quandaries in running clinical trials. The second day will be closed to the public to shield trade secrets.

Several research teams are racing to build artificial placentas that replicate the uterine environment and give the very prematurely born a better shot at survival. A team at the Children’s Hospital of Philadelphia, led by Alan Flake, is the closest to human trials — their device is a bag filled with sterile fluid, which contains the fetus and is connected to tubes providing oxygen and nutrition.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： Rep. Raul Ruiz on the physician shortage and more

explore

WSS

Will the market for weight loss drugs really reach $100 billion?

What don’t we know about an Alzheimer’s drug side effect?

AI used to predict Covid

Merck to buy EyeBio, maker of eye drug, as it grows pipeline

Mayo Clinic plans $5B tech

First Opinion Podcast: What happens when kids become caregivers?

focus

entertainment

hotspot

Anesthesiologist group: stop taking Ozempic before surgery

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Diagnostic tests are hitting their mathematical limits

Peter Hotez and the public health issue of online harassment

U.K. Biobank has 500,000 peoples' genome sequences available

Novavax promises a turnaround & Lilly roils the obesity market

Startling documents reveal new facets of Sacklers' opioid empire

Heart attack and stroke risk calculators need revising

Stigma and the return of syphilis

focus

Scientists successfully use ultrasound imaging to map brain activity

Akili, maker of video game for ADHD, to be acquired for 34 million

First Opinion Podcast: What happens when kids become caregivers?

Is mRNA technology the right fit for flu shots? Experts aren’t so sure

ReNAgade cuts staff seven months after raising $300 million

Readout Newsletter: The latest in Pfizer, Moderna, and Sanofi

explore

knowledge

Wikipedia

focus